Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cow's Milk Allergy in Multiple Sclerosis Patients



Ashtari F1 ; Jamshidi F1 ; Shoormasti RS2 ; Pourpak Z2 ; Akbari M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Research in Medical Sciences Published:2013

Abstract

Background: Exposure to some environmental agent such as different nutrition and contact with allergens may have a role in developing multiple sclerosis (MS). The present study was aimed to evaluate the cow's milk allergy (CMA) in MS patients compared to healthy controls. Materials and Methods: Between March 2012 and July 2012, 48 MS patients were selected and compared with 48 healthy subjectsto assess the frequency of CMA in MS patients compared to healthy control.Cow's milk specific immunoglobin E (IgE) was determined by Immuno CAP. Sex and the frequency of CMA were compared between study groups by Chi-square test. Results: Total of 96 subjects were assessed (22% male and 78% female). The mean age of the study subjects was 30.8 ± 6.6 years. Mean age of case and control groups was 30.7 (±6.9) versus 30.9 ± 6.3, respectively (P value = 0.83). There were no detection of cow's milk specific IgE in serum of MS patients and healthy subjects. Conclusion: There was no difference between MS and healthy subjects regarding CMA.
Related Docs
View other Related Docs
1. The Effects of Different Kinds of Nutrition and Functional Foods on Multiple Sclerosis, Current Nutrition and Food Science (2020)
2. Association of Dietary Patterns With Systemic Inflammation, Quality of Life, Disease Severity, Relapse Rate, Severity of Fatigue and Anthropometric Measurements in Ms Patients, Nutritional Neuroscience (2020)
3. Several Food Items and Multiple Sclerosis: A Case-Control Study in Ahvaz (Iran), Iranian Journal of Nursing and Midwifery Research (2014)
4. A Comparative Study of 25 (Oh) Vitamin D Serum Levels in Patients With Multiple Sclerosis and Control Group in Isfahan, Iran, International Journal of Preventive Medicine (2010)
5. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
6. Investigation of Erg Gene Expression in Iranian Patients With Multiple Sclerosis, Immunological Investigations (2018)
7. Comparison of Ox40 Expression in Patients With Multiple Sclerosis and Neuromyelitis Optica As an Approach to Diagnosis, Allergy, Asthma and Clinical Immunology (2023)
8. Can Vitamin D Suppress Endothelial Cells Apoptosis in Multiple Sclerosis Patients?, International Journal of Preventive Medicine (2013)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (58)
Vahid Shaygannejad (41)
Other Related Docs
9. A Case-Control Study of Risk Factors for Multiple Sclerosis in Iran, Multiple Sclerosis Journal (2011)
10. The Role of Dietary Antioxidant Index and Index of Nutritional Quality in Ms Onset: Finding From an Iranian Population-Based Incident Case–Control Study, Nutritional Neuroscience (2022)
11. Additive Interaction Between Dietary Inflammatory Index and Some Key Risk Factors of Multiple Sclerosis: A Population-Based Incident Case–Control Study, Nutritional Neuroscience (2023)
12. Interleukin-33 Plasma Levels in Patients With Relapsing-Remitting Multiple Sclerosis, Biomolecular Concepts (2017)
13. The Role of Nutritional Factors During Adolescence in Multiple Sclerosis Onset: A Population-Based Incident Case–Control Study, Nutritional Neuroscience (2021)
14. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
15. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
16. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
17. An 8-Year Study of People With Multiple Sclerosis in Isfahan, Iran: Association Between Environmental Air Pollutants and Severity of Disease, Journal of Neuroimmunology (2018)
18. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
19. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
20. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
21. Male Microchimerism in Peripheral Blood From Women With Multiple Sclerosis in Isfahan Province, International Journal of Immunogenetics (2020)
22. Prevalence of Hypothyroidism Among Patients With Multiple Sclerosis Referred to Multiple Sclerosis Clinic of Alzahra Hospital, Isfahan, Iran, During 2014-2015, Journal of Isfahan Medical School (2016)
23. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
24. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
25. Outcome of Covid-19 Infection in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies, Journal of Research in Medical Sciences (2021)
26. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)
27. Association of Exposure to Particulate Matters and Multiple Sclerosis: A Systematic Review and Meta-Analysis, NeuroImmunoModulation (2022)
28. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study, Neurology (2022)
29. Prognostic Value of Intrathecal Igg Synthesis in Multiple Sclerosis: A Study in 54 Patients, Tehran University Medical Journal (2008)
30. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
31. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
32. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
33. 25-Hydroxyvitamin D Concentrations in Patients With Optic Neuritis As a Clinically Isolated Syndrome and Healthy Controls, International Journal of Preventive Medicine (2012)
34. Comparing Body Image in Ms Patients and Healthy Individuals, International Journal of Body, Mind and Culture (2020)
35. Th1, Th2 and Th17 Cytokine Profile in Patients With Multiple Sclerosis Following Treatment With Rapamycin, Iranian Journal of Immunology (2016)
36. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
37. Evaluation of the Prevalence of Bovine Leukemia Virus Dna in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, IJID Regions (2023)
38. Pemphigus Vulgaris in a Patient With Multiple Sclerosis: A Case Report With 7 Years of Follow Up, Journal of Research in Dental and Maxillofacial Sciences (2023)
39. Multiple Sclerosis Is Associated With Worse Covid-19 Outcomes Compared to the General Population: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
40. The Global Prevalence of Familial Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis, BMC Neurology (2021)
41. Prevalence of Cognitive Impairment (Ci) in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Caspian Journal of Internal Medicine (2024)
42. Prenatal and Perinatal Factors Associated With Developing Multiple Sclerosis Later in Life: A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2021)
43. Comparing the Frequency of Tim-3 Polymorphism in Multiple Sclerosis Patients With Healthy Controls, Journal of Isfahan Medical School (2015)
44. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)
45. Evaluation of the Expressed Mir‑129 and Mir‑549A in Patients With Multiple Sclerosis, Advanced Biomedical Research (2021)
46. The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica, Basic and Clinical Neuroscience (2021)
47. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
48. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)
49. Color Blindness Among Multiple Sclerosis Patients in Isfahan, Journal of Research in Medical Sciences (2012)
50. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)